LeadIQ logo
Learn more at LeadIQ.com

Insights

Strong Funding Growth Capricor recently secured $150 million through a public stock offering, indicating substantial financial backing that supports expanding manufacturing capabilities and accelerating product development, offering opportunities for supply chain and manufacturing partnership solutions.

Innovative Therapeutics Specializing in cell and exosome-based therapies for rare diseases like Duchenne muscular dystrophy, Capricor's focus on cutting-edge biologics presents potential for collaborations in clinical research, biologics supply, and biotech tools.

Strategic R&D Focus With ongoing Phase 3 clinical trials and innovative exosome delivery methods, Capricor might be interested in advanced research services, specialized laboratory equipment, or clinical trial support solutions.

Leadership & Expertise The appointment of a new Chief Medical Officer signals ongoing strategic hiring and leadership enhancement, creating opportunities for executive recruitment services and medical consulting partnerships.

Regulatory & Legal Activities The recent class action lawsuit may open avenues for legal advisory services, risk management solutions, or compliance consulting, as the company manages ongoing legal and regulatory challenges.

Similar companies to Capricor Therapeutics, Inc.

Capricor Therapeutics, Inc. Tech Stack

Capricor Therapeutics, Inc. uses 8 technology products and services including SAS, Microsoft Outlook, Twemoji, and more. Explore Capricor Therapeutics, Inc.'s tech stack below.

  • SAS
    Business Intelligence
  • Microsoft Outlook
    Email
  • Twemoji
    Font Scripts
  • jQuery
    Javascript Libraries
  • Office 365
    Office Suites
  • HSTS
    Security
  • Google Tag Manager
    Tag Management
  • Apache HTTP Server
    Web Servers

Media & News

Capricor Therapeutics, Inc.'s Email Address Formats

Capricor Therapeutics, Inc. uses at least 1 format(s):
Capricor Therapeutics, Inc. Email FormatsExamplePercentage
FLast@capricor.comJDoe@capricor.com
50%
FLast@capricor.comJDoe@capricor.com
50%

Frequently Asked Questions

Where is Capricor Therapeutics, Inc.'s headquarters located?

Minus sign iconPlus sign iconCapricor Therapeutics, Inc.'s main headquarters is located at 10865 Road to The Cure, Suite 150. The company has employees across 4 continents, including North AmericaAsiaEurope.

What is Capricor Therapeutics, Inc.'s phone number?

Minus sign iconPlus sign icon You can contact Capricor Therapeutics, Inc.'s main corporate office by phone at
+1-310-358-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Capricor Therapeutics, Inc.'s stock symbol?

Minus sign iconPlus sign iconCapricor Therapeutics, Inc. is a publicly traded company; the company's stock symbol is CAPR.

What is Capricor Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign iconCapricor Therapeutics, Inc.'s official website is capricor.com and has social profiles on LinkedInCrunchbase.

How much revenue does Capricor Therapeutics, Inc. generate?

Minus sign iconPlus sign icon As of December 2025, Capricor Therapeutics, Inc.'s annual revenue is estimated to be $3.2M.

What is Capricor Therapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign iconCapricor Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Capricor Therapeutics, Inc. have currently?

Minus sign iconPlus sign iconAs of December 2025, Capricor Therapeutics, Inc. has approximately 201 employees across 4 continents, including North AmericaAsiaEurope. Key team members include Chief Medical Officer: M. B.Chief Development Officer (cdo): M. A.Vice President Clinical Operations: K. B.. Explore Capricor Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Capricor Therapeutics, Inc. belong to?

Minus sign iconPlus sign iconCapricor Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does Capricor Therapeutics, Inc. use?

Minus sign iconPlus sign iconCapricor Therapeutics, Inc.'s tech stack includes SASMicrosoft OutlookTwemojijQueryOffice 365HSTSGoogle Tag ManagerApache HTTP Server.

What is Capricor Therapeutics, Inc.'s email format?

Minus sign iconPlus sign iconCapricor Therapeutics, Inc.'s email format typically follows the pattern of FLast@capricor.com. Find more Capricor Therapeutics, Inc. email formats with LeadIQ.

When was Capricor Therapeutics, Inc. founded?

Minus sign iconPlus sign iconCapricor Therapeutics, Inc. was founded in 2005.

Capricor Therapeutics, Inc.

Biotechnology ResearchCalifornia, United States201-500 Employees

Capricor Therapeutics is a publicly traded (NASDAQ: CAPR) biotechnology company with a mission to develop groundbreaking therapies that make a meaningful impact on patients’ lives. Capricor is focused on the development of biologics, primarily cell and exosome-based technologies to treat or prevent a broad range of diseases. Our lead product is a cell therapy designed to treat Duchenne muscular dystrophy (DMD), the most severe form of muscular dystrophy, which results in muscle degeneration and premature death. Capricor’s innovative exosome technology is focusing on engineering exosomes to treat or prevent diseases with high unmet medical needs. Our translational approach to product development is based on the strong research foundation provided by our academic partnerships with leading scientists at top-tier research institutions.

Section iconCompany Overview

Headquarters
10865 Road to The Cure, Suite 150
Phone number
+1-310-358-****
Website
capricor.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
CAPR
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2005
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $25M$50M

    Capricor Therapeutics, Inc.'s revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $25M$50M

    Capricor Therapeutics, Inc.'s revenue is estimated to be in the range of $25M$50M

Company Leadership

  • Stylized image of a person
    M. B.
    Chief Medical Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. A.
    Chief Development Officer (cdo)
    Phone icon
    Mobile Phone
  • Stylized image of a person
    K. B.
    Vice President Clinical Operations
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. A.
    Vp Of Biomentrics & Data Management
    Phone icon
    Mobile Phone
  • Stylized image of a person
    G. D.
    Vice President Of Biometrics And Data Management
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    K. M.
    Head Of Biometrics, Senior Director Of Biostatistics
    Phone icon
    Mobile Phone
  • Stylized image of a person
    K. B.
    Vice President Clinical Operations
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. A.
    Vp Of Biomentrics & Data Management
    Phone icon
    Mobile Phone
  • Stylized image of a person
    G. D.
    Vice President Of Biometrics And Data Management
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. R.
    Vice President Clinops
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.